Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy

Acta Haematologica

Volumn 97, Issue 4, 1997, Pages 228-230

  Pogliani, E M ^a,b   Rossini, F ^a,b   Casaroli, I ^a,b   Maffe P ^a,b   Corneo, G ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute promyelocytic leukemia therapy; Acute renal failure; All trans retinoic acid toxicity; Thrombosis

Indexed keywords

HEPARIN; RETINOIC ACID; TRANEXAMIC ACID;

ACUTE KIDNEY FAILURE; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DRUG CHOICE; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; PRIORITY JOURNAL; SYMPTOM; THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION FACTORS; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRINOLYSIS; HEMORRHAGE; HEPARIN; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY GLOMERULUS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; THROMBOSIS; TRETINOIN;

EID: 0030985688     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203689     Document Type: Article

References (13)

1. Hoyle CF, Swirsky DM, Freedman L, Hayhoe FGJ: Beneficial effect of heparin in the management of patients with APL. Br J Haematol 1988;68:283-289.
2. Keane TJ, Gorman AM, O’Connel CG, Fcm-mally JJ: e-aminocaproic acid in the management of APL. Acta Haematol 1976:55:202-208.
3. Dombret H, Scrobohaci ML, Chorra P. Zini JM, Daniel MT, Castaigne S, Degos L: Coagulation disorders associated with APL: Corrective effect of all-trans-retinoic acid treatment. Leukemia 1993;7:2-9.
4. Fenaux P, Castaigne, S Dombret H: All-trans-retinoic acid (ATRA) as first-line therapy of APL: A report of 31 cases. Br J Haematol 1991; 77:51.
5. Escudier S, Kantarjian H, Estey E: Thrombosis in APL patients treated with ATRA. Proc ASCO 1993; 12:310.
6. Runde V, Aul C, Heyll A, Shncider W: All-trans-retinoic acid: Not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia. Blood 1992;79:534-535.
7. Degos L: Is acute promyelocytic leukemia a curable disease? Treatment strategy for a longterm survival. Leukemia 1994;8(suppl 2):96-98.
8. Fenaux P. Castaigne S, Dombret H. Archim-baud E, Duarte M, Morel P. Lamy T, Tilly H, Guerci A, Maloiscl F, Bordcssoule D, Sadoun A, Tiberghien P. Fegueux N, Daniel MT, Chomienne C, Degos L: All-trans-retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyclo-cytic leukemia: A pilot study on 26 cases. Blood 1992;8:2176-2181.
9. Degos L, Dombret H, Chomienne C. Daniel MT, Midea JM, Chastang C, Castaigne S, Fcn-aux P: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995;85:2643-2653.
10. Rodighero F. Castaman G: The pathophysiology and treatment of haemorrhagic syndrome of APL. Leukemia 1994;8(suppl 2):920-926.
11. Dombret H, Scrobohaci ML, Daniel MT, Mi-clea JM, Castaigne S, Chomienne C, Fenaux P, Degos L: In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): Effect of all-trans-retinoic acid (ATRA) therapy. Leukemia 1995;9:19-24.
12. Dc Lacerda JF. Do Carmo JA, Guerra ML, Geraldes J. De Lacerda JMF: Multiple thrombosis in acute promyelocytic leukemia after tretinoin. Lancet 1993;342:114-115.
13. Hashimoto S, Koike T, Tatcwaki W, Seki Y. Sato N, Azegami T. Tsukada N, Takahashi H, Kimcra H, Ueno M, Arakawa M, Shibata A: Fatal thromboembolism in acute promyelocytic leuxemia during all-trans-retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 1994;8: 1113-1115.